IL23A and psoriasis: Recent studies have highlighted the pathogenic role of the IL‐23/Th17 axis in psoriasis, a chronic inflammatory skin disorder affecting the skin in 1–3% of the general population (Nestle et al, 2009; Lowes et al, 2013).